U.S./Canada daily earnings hits & misses Feb 18 - 0900 ET

Tue Feb 18, 2014 2:00pm GMT

Feb 18 (Reuters) - The following U.S.-listed companies reported earnings on Tuesday. This list shows whether they beat, met or
missed Wall Street analysts' forecasts. It also shows the difference between analysts' expectations and reported results. The figures
are provided by Thomson Reuters I/B/E/S.
    
    
 Company Name              Ticker      Qtr  Industry                  Curr  EPS Est  EPS Act Diff EPS  Rev Est  Rev Act Diff Rev
 ACTIVE POWER INC                      Q4   ELECTRONIC SYST/DEVICES    USD    -0.15       --       --     13.1     13.9      0.9
 AMERICAN WOODMARK CORP                Q3   HOME FURNISHINGS           USD     0.29     0.18    -0.11    171.2    169.0     -2.2
 CAPELLA EDUCATION CO                  Q4   UNDESIGNATED CONR SVC      USD     0.76     0.79     0.03    106.4    106.0     -0.5
 CHOICE HOTELS INTL INC                Q4   LEISURE                    USD     0.46     0.46     0.01    185.3    180.7     -4.7
 COCA-COLA CO                          Q4   BEVERAGES                  USD     0.46     0.46     0.00  11310.1       --       --
 DAKTRONICS  INC                       Q3   OTHER COMPUTERS            USD     0.08     0.07    -0.01    120.0    115.4     -4.6
 DENTSPLY INTERNATIONAL                Q4   MEDICAL SUPPLIES           USD     0.61     0.61     0.00    767.9    753.7    -14.2
 DUKE ENERGY CORP                      Q4   ELECTRICAL UTILITIES       USD     0.95     1.00     0.05   6322.7   6112.0   -210.7
 EDUCATION REALTY TRUST                Q4   INVESTMENTS                USD     0.07     0.05    -0.02     48.6     51.1      2.5
 FRESH DEL MONTE                       Q4   FOOD PROCESSORS            USD    -0.16    -0.35    -0.19    791.1    879.9     88.9
 GENESIS ENERGY LP                     Q4   OIL                        USD     0.36     0.20    -0.16   1446.9    961.0   -485.9
 GOVERNMENT PROPERTIES                 Q4   INVESTMENTS                USD     0.27     0.23    -0.04     57.2     58.3      1.1
 HEALTHCARE TRUST OF AMER              Q4   INVESTMENTS                USD     0.04     0.02    -0.02     82.5       --       --
 INTELLIPHARMACEUTICS INT              Q4   DRUGS                      USD    -0.08    -0.31    -0.23      1.1      1.5      0.4
 LCA-VISION INCORPORATED               Q4   HOSPITALS                  USD    -0.08    -0.08     0.00     20.6     20.6      0.1
 MANNKIND CORP                         Q4   DRUGS                      USD    -0.14    -0.16    -0.02      0.4      0.0     -0.4
 MEDTRONIC INC                         Q3   MEDICAL SUPPLIES           USD     0.91     0.91     0.00   4150.4   4163.0     12.6
 NATIONAL HEALTH INVS INC              Q4   INVESTMENTS                USD     0.70     0.83     0.13     31.7     32.8      1.1
 NISOURCE INC                          Q4   ELECTRICAL UTILITIES       USD     0.46     0.47     0.01   1530.0   1592.6     62.6
 NOVA MEASURING                        Q4   SEMICONDUCTORS/COMPONENT   USD     0.15     0.15     0.00     28.9     30.2      1.3
 ORBOTECH LTD                          Q4   PHOTO-OPTICAL EQUIPMENT    USD     0.33     0.30    -0.03    122.4    122.2     -0.2
 STEPAN COMPANY                        Q4   CHEMICALS                  USD     0.86     0.62    -0.24    463.6    474.3     10.7
 UNITED FIRE & CAS CO                  Q4   INSURANCE                  USD     0.62     1.00     0.39    222.4    229.0      6.6
 USA COMPRESSION PARTNERS              Q4   MACHINERY                  USD     0.20     0.12    -0.08     47.5     48.6      1.2
 VASCO DATA SECURITY INTL              Q4   SOFTWARE & EDP SERVICES    USD     0.06     0.09     0.03     40.0     43.3      3.3
 WASTE MANAGEMENT INC                  Q4   MACHINERY                  USD     0.61     0.56    -0.05   3578.8   3500.0    -78.8
 WOLVERINE WORLD WIDE INC              Q4   CLOTHING                   USD     0.20     0.22     0.02    743.9    740.8     -3.1
 

 (Bangalore Newsroom +91 80 4135 5800; within U.S. +1 646 223 8780)
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.